Work

Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial

Year: 2018

Type: article

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/rccm.201710-2052le

Authors: Bartolome Celli, Julie A. Anderson, Robert Brook, Peter Calverley, Courtney Crim, Andrew P. Holmes, Fernando J. Martinez, David E. Newby, Julie Yates, Jørgen Vestbo

Institutions: Brigham and Women's Hospital, GlaxoSmithKline (United Kingdom), University of Michigan, University of Liverpool, GlaxoSmithKline (United States), Cornell University, Weill Cornell Medicine, University of Edinburgh, University of Manchester

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2792141570

FWCI: 0.565

Cites: 8

Cited by: 3

Related to: 10